報價延遲最少15分鐘:2026/10/01 14:02 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
26.475 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
1.47/2.36
|
|
企業價值
14.46B
|
| 資產負債 |
|
每股賬面淨值
12.38
|
| 現金流量 |
|
現金流量率
0.12
|
| 損益表 |
|
收益
3.96B
|
|
每股收益
12.78
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 40% of the UK-based firm's revenue comes from orthopedic products, and another 31% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the US, just over 30% is from other developed markets, and emerging markets account for the remainder. |
